Proteomics International Laboratories Management
Management criteria checks 3/4
Proteomics International Laboratories' CEO is Richard Lipscombe, appointed in Jan 2001, has a tenure of 23.83 years. total yearly compensation is A$415.35K, comprised of 87.9% salary and 12.1% bonuses, including company stock and options. directly owns 12.53% of the company’s shares, worth A$11.16M. The average tenure of the management team and the board of directors is 3.1 years and 2.6 years respectively.
Key information
Richard Lipscombe
Chief executive officer
AU$415.3k
Total compensation
| CEO salary percentage | 87.9% |
| CEO tenure | 23.8yrs |
| CEO ownership | 12.5% |
| Management average tenure | 3.1yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable
Nov 16
Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being
Nov 17Recent updates
Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable
Nov 16Calculating The Fair Value Of Proteomics International Laboratories Limited (ASX:PIQ)
Sep 29We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely
May 10Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being
Nov 17Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?
Aug 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$415k | AU$365k | -AU$6m |
| Mar 31 2024 | n/a | n/a | -AU$6m |
| Dec 31 2023 | n/a | n/a | -AU$6m |
| Sep 30 2023 | n/a | n/a | -AU$6m |
| Jun 30 2023 | AU$442k | AU$350k | -AU$6m |
| Mar 31 2023 | n/a | n/a | -AU$6m |
| Dec 31 2022 | n/a | n/a | -AU$6m |
| Sep 30 2022 | n/a | n/a | -AU$5m |
| Jun 30 2022 | AU$330k | AU$265k | -AU$5m |
| Mar 31 2022 | n/a | n/a | -AU$5m |
| Dec 31 2021 | n/a | n/a | -AU$4m |
| Sep 30 2021 | n/a | n/a | -AU$4m |
| Jun 30 2021 | AU$298k | AU$250k | -AU$3m |
| Mar 31 2021 | n/a | n/a | -AU$3m |
| Dec 31 2020 | n/a | n/a | -AU$2m |
| Sep 30 2020 | n/a | n/a | -AU$2m |
| Jun 30 2020 | AU$299k | AU$250k | -AU$2m |
| Mar 31 2020 | n/a | n/a | -AU$2m |
| Dec 31 2019 | n/a | n/a | -AU$2m |
| Sep 30 2019 | n/a | n/a | -AU$2m |
| Jun 30 2019 | AU$207k | AU$185k | -AU$2m |
| Mar 31 2019 | n/a | n/a | -AU$2m |
| Dec 31 2018 | n/a | n/a | -AU$2m |
| Sep 30 2018 | n/a | n/a | -AU$2m |
| Jun 30 2018 | AU$156k | AU$170k | -AU$1m |
Compensation vs Market: Richard's total compensation ($USD270.06K) is about average for companies of similar size in the Australian market ($USD298.50K).
Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.
CEO
Richard Lipscombe
23.8yrs
Tenure
AU$415,346
Compensation
Dr. Richard John Lipscombe, Ph D (London), MA (Oxford), co-founded Proteomics International Laboratories Limited in 2001 and serves as its Managing Director and Director since June 09, 2014. Mr. Lipscombe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 23.8yrs | AU$415.35k | 12.53% A$ 11.2m | |
| CFO & Head of Corporate Development | 3.3yrs | AU$445.81k | 0.049% A$ 43.6k | |
| Head of Business Development | no data | no data | no data | |
| Head of Research | 2.8yrs | no data | no data | |
| Head of Product Development | 2.3yrs | no data | no data | |
| Head of Clinical Studies | no data | no data | no data | |
| Company Secretary | no data | no data | no data |
3.1yrs
Average Tenure
Experienced Management: PIQ's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 10.4yrs | AU$415.35k | 12.53% A$ 11.2m | |
| Independent Non-Executive Director | 3yrs | AU$87.37k | 0.090% A$ 80.0k | |
| Member of Clinical Advisory Board | 2.6yrs | no data | no data | |
| Independent Non-Executive Director | 7yrs | AU$52.45k | 0.79% A$ 704.8k | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | 2.6yrs | no data | no data | |
| Member of Clinical Advisory Board | 2.6yrs | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | 2.6yrs | no data | no data | |
| Member of Clinical Advisory Board | 2.6yrs | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Non- Executive Chairman | less than a year | no data | no data |
2.6yrs
Average Tenure
Experienced Board: PIQ's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.